Commodore Capital as of June 30, 2022
Portfolio Holdings for Commodore Capital
Commodore Capital holds 24 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 12.5 | $59M | 2.6M | 22.64 | |
| Xenon Pharmaceuticals (XENE) | 10.3 | $49M | 1.6M | 30.42 | |
| Cogent Biosciences (COGT) | 9.4 | $45M | 4.9M | 9.02 | |
| Bellus Health Com New | 8.8 | $41M | 4.5M | 9.24 | |
| Cytokinetics Com New (CYTK) | 7.4 | $35M | 894k | 39.29 | |
| Aclaris Therapeutics (ACRS) | 7.1 | $34M | 2.4M | 13.96 | |
| Kura Oncology (KURA) | 7.1 | $34M | 1.8M | 18.33 | |
| Iveric Bio | 4.9 | $23M | 2.4M | 9.62 | |
| Tricida | 4.2 | $20M | 2.0M | 9.68 | |
| Miragen Therapeutics (VRDN) | 4.0 | $19M | 1.6M | 11.57 | |
| Cymabay Therapeutics | 3.6 | $17M | 5.7M | 2.95 | |
| Satsuma Pharmaceuticals Ord | 3.2 | $15M | 3.7M | 4.14 | |
| Celldex Therapeutics Com New (CLDX) | 3.1 | $15M | 539k | 26.96 | |
| Day One Biopharmaceuticals I (DAWN) | 2.8 | $13M | 740k | 17.90 | |
| Vistagen Therapeutics Com New | 2.4 | $12M | 13M | 0.88 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.3 | $11M | 313k | 35.21 | |
| Karyopharm Therapeutics (KPTI) | 1.8 | $8.7M | 1.9M | 4.51 | |
| Celcuity (CELC) | 1.8 | $8.4M | 921k | 9.10 | |
| Rezolute Com New (RZLT) | 0.8 | $3.9M | 1.2M | 3.23 | |
| Immunic (IMUX) | 0.7 | $3.1M | 893k | 3.47 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $3.1M | 313k | 9.84 | |
| Bcls Acquisition Corp Com Cl A | 0.5 | $2.5M | 250k | 9.90 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $2.0M | 358k | 5.63 | |
| Inventiva Sa Ads (IVA) | 0.2 | $995k | 176k | 5.67 |
